Lost in translation: preclinical studies on 3,4‐methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans

No abstract is available for this paper.

• Publication year

  2012

• Venue

  British Journal of Pharmacology

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1476-5381.2011.01819.xPMID 22188379PMCID PMC3419898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats

  2011cited by this paper
• MDMA: interactions with other psychoactive drugs.

  2011cited by this paper
• Translational neuropharmacology and the appropriate and effective use of animal models

  2011cited by this paper
• The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

  2011cited by this paper
• Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users.

  2011cited by this paper
• Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans

  2011cited by this paper
• Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Baboons after Oral Administration: Comparison with Humans Reveals Marked Differences

  2011cited by this paper
• Investigation on the Enantioselectivity of the Sulfation of the Methylenedioxymethamphetamine Metabolites 3,4-Dihydroxymethamphetamine and 4-Hydroxy-3-Methoxymethamphetamine using the Substrate-Depletion Approach

  2011cited by this paper
• Instability of the ecstasy market and a new kid on the block: mephedrone

  2011cited by this paper
• Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases.

  2011cited by this paper
• MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings.

  2010cited by this paper
• Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

  2010cited by this paper
• Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT

  2010cited by this paper
• Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): human and animal data.

  2010cited by this paper
• The role of monoamines in the changes in body temperature induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives

  2010cited by this paper
• Optimising in vivo pharmacology studies--Practical PKPD considerations.

  2010cited by this paper
• Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview

  2009cited by this paper
• Comment on the letter by Green, Gabrielsson, Marsden, and Fone, MDMA: on the translation from rodent to human dosing

  2009cited by this paper
• Annual Report 2009: the state of the drugs problem in Europe

  2009cited by this paper
• Effects of Dose and Route of Administration on Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine in the Rat

  2009influential reference
• Quantitative Pharmacology or Pharmacokinetic Pharmacodynamic Integration Should Be a Vital Component in Integrative Pharmacology

  2009cited by this paper
• On the Mechanisms Underlying 3,4-Methylenedioxymethamphetamine Toxicity: The Dilemma of the Chicken and the Egg

  2009cited by this paper
• Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).

  2009cited by this paper
• Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations.

  2009cited by this paper
• A framework to assess the translation of safety pharmacology data to humans.

  2009influential reference
• MDMA: On the translation from rodent to human dosing

  2009cited by this paper
• Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity

  2009cited by this paper
• Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine After Controlled Oral Administration to Young Adults

  2008influential reference
• A single dose

  2008cited by this paper
• The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity

  2008cited by this paper
• On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats.

  2008cited by this paper
• Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat.

  2008cited by this paper
• MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt

  2008cited by this paper
• Impact of Ambient Temperature on Hyperthermia Induced by (±)3,4-Methylenedioxymethamphetamine in Rhesus Macaques

  2007cited by this paper
• Pharmacological Interaction between 3,4-Methylenedioxymethamphetamine (Ecstasy) and Paroxetine: Pharmacological Effects and Pharmacokinetics

  2007cited by this paper
• Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.

  2007cited by this paper
• MDMA, politics and medical research: Have we thrown the baby out with the bathwater?

  2007cited by this paper
• Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons

  2006cited by this paper
• Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA

  2006cited by this paper
• L-Tyrosine Contributes to (+)-3,4-Methylenedioxymethamphetamine-Induced Serotonin Depletions

  2006cited by this paper
• Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain

  2006cited by this paper
• Neurotoxicity of Ecstasy Metabolites in Rat Cortical Neurons, and Influence of Hyperthermia

  2006cited by this paper
• The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents.

  2006cited by this paper
• Ecstasy: Are animal data consistent between species and can they translate to humans?

  2006cited by this paper
• MDMA‐induced neurotoxicity: long‐term effects on 5‐HT biosynthesis and the influence of ambient temperature

  2006cited by this paper
• Information on "Ecstasy".

  2006cited by this paper
• Is there a case for MDMA-assisted psychotherapy in the UK?

  2006cited by this paper
• MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress

  2006cited by this paper
• Serotonergic Neurotoxic Metabolites of Ecstasy Identified in Rat Brain

  2005cited by this paper
• Studies on the effect of MDMA (‘ecstasy’) on the body temperature of rats housed at different ambient room temperatures

  2005cited by this paper
• MDMA and MDA concentrations in antemortem and postmortem specimens in fatalities following hospital admission.

  2005cited by this paper
• Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

  2005cited by this paper
• A comparative study on the acute and long‐term effects of MDMA and 3,4‐dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

  2005cited by this paper
• Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

  2004influential reference
• Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones

  2004cited by this paper
• MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press

  2004cited by this paper
• Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity.

  2004cited by this paper
• Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated (‘binge’ ingestion) low dose of MDMA

  2004cited by this paper
• Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function

  2004cited by this paper
• Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.

  2004cited by this paper
• ynthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy)

  2003cited by this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003influential reference
• Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

  2003cited by this paper
• Comparison of ( )-11 C-McN 5652 and 11 C-DASB as Serotonin Transporter Radioligands Under Various Experimental Conditions

  2002cited by this paper
• Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity

  2002cited by this paper
• Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.

  2002cited by this paper
• The content of ecstasy tablets: implications for the study of their long-term effects.

  2002cited by this paper
• 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

  2002cited by this paper
• Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity

  2002cited by this paper
• The pharmacology of the acute hyperthermic response that follows administration of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats

  2002cited by this paper
• Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.

  2001cited by this paper
• 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

  2001influential reference
• Caveat Emptor: Editors Beware

  2001cited by this paper
• Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.

  2001cited by this paper
• Caveat Emptor: Editors Beware

  2001cited by this paper
• A study of the mechanisms involved in the neurotoxic action of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain

  2001influential reference
• Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans.

  2000cited by this paper
• Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy').

  2000cited by this paper
• Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.

  2000cited by this paper
• The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers

  2000cited by this paper
• MDMA Study

  1999cited by this paper
• Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.

  1999cited by this paper
• Is A Single Dose of MDMA Harmless

  1999cited by this paper
• Caveat Emptor: Researcher Beware

  1999cited by this paper
• Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans.

  1999cited by this paper
• Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats.

  1999cited by this paper
• Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity.

  1999cited by this paper
• N‐tert‐butyl‐alpha‐phenylnitrone protects against 3,4‐methylenedioxymethamphetamine‐induced depletion of serotonin in rats

  1999cited by this paper
• Studies on the role of dopamine in the degeneration of 5‐HT nerve endings in the brain of Dark Agouti rats following 3,4‐methylenedioxymethamphetamine (MDMA or ‘ecstasy’) administration

  1999cited by this paper
• Hallucinogens at the turn of the century: an introduction.

  1998cited by this paper
• In vivo detection of short‐ and long‐term MDMA neurotoxicity—a positron emission tomography study in the living baboon brain

  1998cited by this paper
• An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.

  1998cited by this paper
• Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat

  1998cited by this paper
• The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

  1998cited by this paper
• Role of hyperthermia in the protective action of clomethiazole against MDMA (‘ecstasy’)‐induced neurodegeneration, comparison with the novel NMDA channel blocker AR‐R15896AR

  1998cited by this paper
• Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

  1998influential reference
• Editors' Introduction: Hallucinogens at the Turn of the Century

  1998cited by this paper
• In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not the degeneration following fenfluramine

  1997cited by this paper
• Tablets often contain substances in addition to, or instead of, ecstasy..

  1996cited by this paper
• Ecstasy and neurodegeneration

  1996cited by this paper

• Ecstasy, molly, MDMA: What health practitioners need to know about this common recreational drug.

  2025cites this paper
• E-cigarettes may serve as a gateway to conventional cigarettes and other addictive drugs

  2023cites this paper
• MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy.

  2023cites this paper
• Toward a New Science of Psychedelic Social Psychology: The Effects of MDMA (Ecstasy) on Social Connection

  2022cites this paper
• Synthetic cathinones

  2022cites this paper
• MDMA and memory, addiction, and depression: dose-effect analysis

  2022cites this paper
• Testing eSlide

  2021cites this paper
• Stem Cells for Next Level Toxicity Testing in the 21st Century.

  2020cites this paper
• Addiction of Hallucinogens, Dissociatives, Designer Drugs and “Legal Highs”: Update on Potential Therapeutic Use

  2020cites this paper
• Mephedrone and MDMA: a comparative review.

  2020cites this paper
• The Research Modernisation Deal

  2020cites this paper
• The spurious relationship between ecstasy use and neurocognitive deficits: A Bradford Hill review.

  2019cites this paper
• Title Cognitive Effects of MDMA in Laboratory Animals : A Systematic Review Focusing on Dose Permalink

  2019cites this paper
• Stimulanzien vom Amphetamin-Typ

  2019cites this paper
• Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose

  2019cites this paper
• 3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats.

  2019cites this paper
• Implicación de la vía kinurenina en los efectos inmediatos y a largo plazo inducidos por 3,4-metilendioximetanfetamina (MDMA, éxtasis) en cerebro de rata

  2019influential citation
• Investigating the effects of repeat ketamine exposure : linking brain structural imaging changes to cellular alterations

  2019cites this paper
• Key interindividual determinants in MDMA pharmacodynamics

  2018influential citation
• Is the recreational use of 3,4-methylenedioxy-methamphetamine safe?

  2018cites this paper
• Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

  2018cites this paper
• E-cigarettes-An unintended illicit drug delivery system.

  2018cites this paper
• Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions

  2018cites this paper
• MDMA‐assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?

  2018cites this paper
• Effects of a combination of 3,4-methylenedioxymeth amphetamine and caffeine on real time stimulated dopamine release in the rat striatum: Studies using fast cyclic voltammetry.

  2017cites this paper
• Navigatingintimacywithecstasy:Theemotional,spatialandboundaried dynamicsofcouples’MDMAexperiences

  2017cites this paper
• Amphetamine‐related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

  2017cites this paper
• Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication

  2017cites this paper
• Advancing Biomedical Research and Regulatory Policies for Human and Animal Health

  2017cites this paper
• 3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner

  2017cites this paper
• Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective

  2016cites this paper
• Verbal memory impairment in polydrug ecstasy users

  2016cites this paper
• MDMA as a Probe and Treatment for Social Behaviors.

  2016cites this paper
• Addiction to Hallucinogens, Dissociatives, Designer Drugs and “Legal Highs”

  2015cites this paper
• Learning, Memory, and Executive Function in New MDMA Users: A 2-Year Follow-Up Study

  2015cites this paper
• MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro

  2014cites this paper
• The preclinical pharmacology of mephedrone; not just MDMA by another name

  2014influential citation
• Nonlinear Pharmacokinetics of (±)3,4-Methylenedioxymethamphetamine (MDMA) and Its Pharmacodynamic Consequences in the Rat

  2014influential citation
• Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)

  2014cites this paper
• Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats

  2014cites this paper
• Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs)

  2014influential citation
• Cathinone increases body temperature, enhances locomotor activity, and induces striatal c-fos expression in the Siberian hamster.

  2014cites this paper
• Current preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by MDMA and methamphetamine.

  2014cites this paper
• Moral panic in Icelandic society: Arrival of ecstasy to Iceland

  2014cites this paper
• Ecstasy, legal highs and designer drug use: A Canadian perspective

  2014cites this paper
• Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA.

  2013cites this paper
• Addictive Behaviors Young adults ' trajectories of Ecstasy use : A population based study

  2013cites this paper
• Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone‐induced hypothermia

  2013cites this paper
• Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research

  2013cites this paper
• Methylenedioxymethamphetamine-induced neurotoxicity: The role of hepatic enzymes cytochrome p450 2d6 and catechol-o-methyltransferase and contribution of microglia

  2013cites this paper
• Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology

  2013cites this paper
• Ecstasy¿s Neurotoxicity: In Vitro Findings from Mitochondria to the Cell

  2013cites this paper
• 'Ecstasy' enhances noise-induced hearing loss.

  2013influential citation
• Dottorato di Ricerca in Tossicologia - Indirizzo Farmacologia e Farmacoterapia delle Tossicodipendenze Ciclo XXVI

  2013cites this paper
• Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology

  2013influential citation
• Chapter 9 – Mephedrone

  2013cites this paper
• Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.

  2013cites this paper
• 5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects.

  2013cites this paper
• Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.

  2013cites this paper
• 3,4-methylenedioxymethamphetamine (MDMA): current perspectives

  2013cites this paper
• Nonlinear Pharmacokinetics of ( 6 )3, 4-Methylenedioxymethamphetamine (MDMA) and Its Pharmacodynamic Consequences in the Rat

  2013influential citation
• Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat.

  2013cites this paper
• Young adults' trajectories of Ecstasy use: a population based study.

  2013cites this paper
• Studies of (±)-3,4-Methylenedioxymethamphetamine (MDMA) Metabolism and Disposition in Rats and Mice: Relationship to Neuroprotection and Neurotoxicity Profile

  2013cites this paper
• 3,4-methylenedioxymethamphetamine (MDMA): current perspectives

  2013cites this paper
• Ecstasy cannot be assumed to be 3,4‐methylenedioxyamphetamine (MDMA)

  2012cites this paper
• MDMA and 5‐HT neurotoxicity: the empirical evidence for its adverse effects in humans – no need for translation

  2012influential citation